Gunpo, South Korea

Se Chan Kang

This inventor holds 1 USPTO granted patent. Top assignee: Sungkyunkwan University. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se Chan Kang. Retrieved from https://idiyas.com/inventor/se-chan-kang-hls8ef1p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se Chan Kang: Inventor in Anticancer Research

Introduction

Se Chan Kang is an inventor based in Gunpo, South Korea. His work includes research on plant-derived compounds with potential anticancer activity. He is associated with Sungkyunkwan University and is credited with 1 patent.

Latest Patents

Kang’s patent describes an extract with anticancer activity and triterpene saponin compounds isolated from it, including saxifragifolin B and saxifragifolin D. The invention reports that these compounds inhibit cancer-cell growth and induce apoptosis, and discusses their potential use in compositions for cancer prevention and treatment. It also describes a method for isolating triterpene saponin compounds from the extract.

Career Highlights

Kang’s listed patent work connects natural-product research with potential therapeutic applications. The patent focuses on identifying and isolating compounds that may support the development of cancer-related treatments.

Collaborations

The supplied information lists Chang Min Lee and Ok Pyo Zee as Kang’s coworkers. Sungkyunkwan University is identified as his affiliated organization.

Conclusion

Se Chan Kang’s patent centers on plant-derived triterpene saponins and their reported effects on cancer cells, reflecting an effort to explore natural compounds for potential cancer prevention and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…